Terns Pharmaceuticals, Inc. (NASDAQ:TERN – Get Free Report) has earned a consensus rating of “Moderate Buy” from the eight brokerages that are covering the stock, Marketbeat reports. Two equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The average 12 month price objective […]
Terns Pharmaceuticals (NASDAQ:TERN) Earns Market Outperform Rating from JMP Securities themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Terns Pharmaceuticals, Inc (NASDAQ:TERN) Receives Average Recommendation of Moderate Buy from Brokerages themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Terns Pharmaceuticals, Inc. (NASDAQ:TERN – Get Free Report) has received an average recommendation of “Moderate Buy” from the nine analysts that are presently covering the company, Marketbeat reports. Two research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The average 12 month price objective […]
Terns Pharmaceuticals (NASDAQ:TERN – Free Report) had its price target upped by Mizuho from $16.00 to $17.00 in a research note issued to investors on Wednesday, FlyOnTheWall reports. Several other research firms have also recently issued reports on TERN. Roth Mkm reissued a buy rating and set a $23.00 target price on shares of Terns […]